A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.
Supply chain issues are interrupting hormone replacement therapy for transgender men and women, both in the U.S. and abroad. Torrin Williams, a 26-year-old warehouse worker in Savannah, Georgia, was ...
NEW YORK (Reuters Health) - Hormone replacement therapy after menopause may interfere with the accuracy of mammograms used to screen for breast cancer -- and the risk may be greater with hormones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback